Lymphatic Filariasis
Population migration is an important consideration in mass drug administration
Published in TB and Outbreaks Week, May 27th, 2003
This was because more inhabitants were available for treatment in January, the peak of the region's agricultural season.
"Annual two-drug, single-dose mass drug administration (MDA) to 80%-90% of the eligible population for 4-6 years are prerequisites for the successful elimination of lymphatic filariasis (LF) from endemic communities by interruption of transmission and eventual elimination of new...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Cryptosporidiosis
Study finds elderly at higher risk of severe disease from water-borne infection - Microbial Infections
Circulating inflammatory mediators predict shock, mortality in febrile patients - Food-borne Illness
Concurrent Shigella and E. coli outbreaks highlight need for food safety - Japanese Encephalitis
Outbreaks in Australia may have been caused by wind-blown Culex mosquitoes - SARS
Lung damage could be from immune response to infection - Shigellosis
Predominant type of S. sonnei common in four sequential outbreaks in Taiwan - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
